noscript

News and Announcements

Immuron Clarifies Terms of Debenture with Paladin Labs.

  • Published February 09, 2012 2:43PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

The Company has become aware of some misinformation regarding the terms of the Convertible Debenture (Agreement) entered into with Paladin Labs Inc. (Paladin), which was announced to the ASX on 16th January 2012. Specifically, the misinformation relates to the assets of the company that are encumbered under the debenture and could have been interpreted to, erroneously, include Immuron’s intellectual property.

Immuron’s Intellectual Property is not encumbered under the Debenture in any way. In view of Immuron’s stated principal focus to commercialize all of its products and intellectual property remains absolutely unfettered. This principle was vital in Immuron’s board unanimously approving the Paladin transaction on 28 November 2011.

—–

To view the full article, please click the link below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now